AMPLY Discovery
- Biotech or pharma, therapeutic R&D
- Biotech or pharma, animal health
Novel Medicines. Designed by Evolution. Discovered by AI.
AMPLY offers design and validation of novel, bioactive peptides and siRNA, in weeks, not years, or partner with us on our existing therapeutic programs in oncology and infectious disease.
Partner with AMPLY to rapidly discover novel potent peptides and siRNA for your target, or license from among our portfolio of anti-infectives and anti-cancer agents.
AMPLY is powering the discovery of new cures for complex diseases, such as cancer, metabolic disease, and infectious diseases, through AI and synthetic biology - making the discovery of new next-generation biologic medicines more predictable and less expensive.
AMPLY actively discovers novel anti-infective peptides for systemic infection, as well as pulmonary, topical, dermatologic and cosmeceutical applications.
AMPLY actively discovers novel anti-cancer siRNA for a wide range of oncology applications, ranging from triple negative breast cancer to leukemia to solid tumor.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}